Skip to content
2000
Volume 26, Issue 9
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background: Streptococcus mutans is one of the bacteria that contributes to biofilm formation and causes dental caries. The inhibition of SrtA, gbpC, and Ag I/II is a promising target to be developed as an antibacterial. Ocimum basilicum is known to have antibacterial activity. Aim and Objective: The aim of this study is to evaluate the potential nevadensin as antibacterial against in-silico. Methods: Antibacterial analysis was carried out by disc diffusion and micro-dilution methods and the in-silico study was performed with ligand-protein docking. Results: The result showed that the MIC and MBC values of nevadensin are 900 and 7200 μg/mL, respectively. The binding energy of nevadensin to SrtA, gbpC, and Ag I/II were -4.53, 8.37, -6.12 kcal/mol, respectively. Conclusion: Nevadensin shows moderate activity as an antibacterial against S. mutans. Meanwhile, in silico studies showed it has the same binding strength as chlorhexidine in inhibiting SrtA, whereas to gbpC and Ag I/II, it has a weaker binding affinity. Therefore, nevadensin has the potential as a natural antibacterial against S. mutans by inhibiting SrtA.

Loading

Article metrics loading...

/content/journals/cchts/10.2174/1386207325666220930122813
2023-08-01
2025-06-28
Loading full text...

Full text loading...

/content/journals/cchts/10.2174/1386207325666220930122813
Loading

  • Article Type:
    Research Article
Keyword(s): Antibacterial; biofilm; ligand-protein; micro-dilution; Nevadensin; Ocimum basilicum
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test